According to Michael S. Schmidt of the New York Times, MLB’s new collective bargaining agreement, which is set to be announced early next week, will include blood testing for human growth hormone (HGH).
Here are some of the details:
The bargaining agreement, which could be announced early next week, calls for blood testing to begin in February, when players report to spring training. Players who test positive will face a 50-game suspension, which will be the same as the first-time penalty for a positive steroid test, according to the two people.
If Schmidt’s report proves correct, baseball will be the first of the major North American professional sports leagues to implement blood testing for drugs among unionized players. The NFL and NFLPA tentatively agreed to test for HGH in their recent collective bargaining agreement, but the union has yet to approve testing procedures. Baseball currently has testing for HGH among minor league players because it doesn’t need the consent of a union. Former major leaguer Mike Jacobs was the first to test positive earlier this year.
It’s definitely a surprise to learn that the players have agreed to blood tests for HGH, but if MLB uses the same type of testing they have in the minor leagues, this could be as much about positive P.R. as actually catching someone. Stay tuned.
The Cubs soundly defeated the Cardinals on Monday night, 10-2, sending their magic number down to one. They will try to clinch the NL Central on Tuesday with another win against the Cardinals. Alternatively, if they lose, they can still clinch if the Brewers also lose on Tuesday.
The Cubs, of course, won the Central last year en route to winning their first World Series since 1908. It wasn’t nearly as easy this year as the club was below .500 entering June and was exactly at .500 entering July. A 16-8 July, 17-12 August, and 15-8 September have helped put the Cubs back in position to return to the postseason.
Not to be forgotten, the Cardinals were eliminated from NL Central contention with Monday’s loss. Now they have their sights set on the second NL Wild Card slot and currently trail the Rockies in that race.
The matchups for Tuesday’s action:
Dennis Lin of the San Diego Union Tribune reports that Padres pitcher Carter Capps will undergo surgery this offseason to address thoracic outlet syndrome, which doctors believe caused the right-hander’s blood clots. The Padres hope to have him ready by spring training next year.
Capps, 27, underwent Tommy John surgery last year and didn’t debut this season until August 7. He made 11 relief appearances, yielding nine runs on 12 hits and two walks with seven strikeouts in 12 1/3 innings. He went back on the DL on September 12 due to the blood clot issue.
The Padres acquired Capps from the Marlins last July in the Andrew Cashner trade which ended up having a lot of moving parts. Capps will enter his third and final year of arbitration eligibility this offseason. It’s quite possible the Padres choose to non-tender him.